Ligand Pharmaceuticals
LGND
LGND
266 hedge funds and large institutions have $2.37B invested in Ligand Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 60 increasing their positions, 130 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 275 → 266 (-9)
46% less call options, than puts
Call options by funds: $75.6M | Put options by funds: $140M
54% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 130
Holders
266
Holding in Top 10
2
Calls
$75.6M
Puts
$140M
Top Buyers
| 1 | +$26.2M | |
| 2 | +$17.6M | |
| 3 | +$8.46M | |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$8.42M |
| 5 |
Morgan Stanley
New York
|
+$8.41M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$22.3M | |
| 3 | -$20.7M | |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$20.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$11M |